870P POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients of performance status 2 with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC).
Saved in:
| Title: | 870P POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients of performance status 2 with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC). |
|---|---|
| Authors: | Forster, M.D.1 (AUTHOR), Mason, J.2 (AUTHOR), Moleron, R.3 (AUTHOR), Sacco, J.J.4 (AUTHOR), Beasley, M.5 (AUTHOR), Reis Ferreira, M.6 (AUTHOR), Srinivasan, D.7 (AUTHOR), Yip, K.8 (AUTHOR), Stewart, G.9 (AUTHOR), Chiu, K.10 (AUTHOR), Ward, A.11 (AUTHOR), Metcalf, R.12 (AUTHOR), Adedoyin, T.13 (AUTHOR), Begum, R.14 (AUTHOR), Chiwewe, M.13 (AUTHOR), Poole, K.13 (AUTHOR), Spanswick, V.15 (AUTHOR), Pathak, Y.15 (AUTHOR), Counsell, N.16 (AUTHOR), Rashid, M.K.17 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS623-S624. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179692327 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 870P POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients of performance status 2 with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Forster%2C+M%2ED%2E%22">Forster, M.D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mason%2C+J%2E%22">Mason, J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moleron%2C+R%2E%22">Moleron, R.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sacco%2C+J%2EJ%2E%22">Sacco, J.J.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Beasley%2C+M%2E%22">Beasley, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reis+Ferreira%2C+M%2E%22">Reis Ferreira, M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Srinivasan%2C+D%2E%22">Srinivasan, D.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yip%2C+K%2E%22">Yip, K.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stewart%2C+G%2E%22">Stewart, G.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chiu%2C+K%2E%22">Chiu, K.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ward%2C+A%2E%22">Ward, A.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Metcalf%2C+R%2E%22">Metcalf, R.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Adedoyin%2C+T%2E%22">Adedoyin, T.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Begum%2C+R%2E%22">Begum, R.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chiwewe%2C+M%2E%22">Chiwewe, M.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Poole%2C+K%2E%22">Poole, K.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Spanswick%2C+V%2E%22">Spanswick, V.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pathak%2C+Y%2E%22">Pathak, Y.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Counsell%2C+N%2E%22">Counsell, N.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rashid%2C+M%2EK%2E%22">Rashid, M.K.</searchLink><relatesTo>17</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS623-S624. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179692327 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.931 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S623 Titles: – TitleFull: 870P POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients of performance status 2 with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Forster, M.D. – PersonEntity: Name: NameFull: Mason, J. – PersonEntity: Name: NameFull: Moleron, R. – PersonEntity: Name: NameFull: Sacco, J.J. – PersonEntity: Name: NameFull: Beasley, M. – PersonEntity: Name: NameFull: Reis Ferreira, M. – PersonEntity: Name: NameFull: Srinivasan, D. – PersonEntity: Name: NameFull: Yip, K. – PersonEntity: Name: NameFull: Stewart, G. – PersonEntity: Name: NameFull: Chiu, K. – PersonEntity: Name: NameFull: Ward, A. – PersonEntity: Name: NameFull: Metcalf, R. – PersonEntity: Name: NameFull: Adedoyin, T. – PersonEntity: Name: NameFull: Begum, R. – PersonEntity: Name: NameFull: Chiwewe, M. – PersonEntity: Name: NameFull: Poole, K. – PersonEntity: Name: NameFull: Spanswick, V. – PersonEntity: Name: NameFull: Pathak, Y. – PersonEntity: Name: NameFull: Counsell, N. – PersonEntity: Name: NameFull: Rashid, M.K. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
